MUC5AC mucin release from human airways in vitro: Effects of indomethacin and Bay X1005
Background: Increased secretion of mucus is a hallmark of many respiratory diseases and contributes significantly to the airflow limitation experienced by many patients. While the current pharmacological approach to reducing mucus and sputum production in patients is limited, clinical studies have s...
Saved in:
Main Authors: | Patricia Roger, Jean-Pierre Gascard, Jacques Bara, Vincent Thomas de Montpreville, Charles Brink |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2001-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629350124329 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Basal Secretion of Lysozyme from Human Airways in Vitro
by: Patricia Roger, et al.
Published: (1999-01-01) -
Adalimumab Treatment in Biologically Naïve Crohn’s Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement
by: Tsutomu Mizoshita, et al.
Published: (2014-01-01) -
CCL4 Affects Eosinophil Survival via the Shedding of the MUC1 N-Terminal Domain in Airway Inflammation
by: Yoshiki Kobayashi, et al.
Published: (2024-12-01) -
Antenatal Indomethacin Treatment for Congenital Myotonic Dystrophy
by: Kyohei Yamaguchi, et al.
Published: (2019-01-01) -
The determination of some biochemical parameters in rats treated with different doses of indomethacin
by: İzzet Karahan, et al.